Radiology Imaging Cancer Podcast | RSNA

Dr. Yashbir Singh talks with Dr. Bonnie Joe about her journey from engineering to breast imaging and how a systematic, analytical approach shapes her clinical practice. Dr. Joe shares insights on breast screening guidelines, dense breast management, health equity, and how AI could help close gaps in access to care. Radiology: Imaging Cancer R&E Foundation

Drs. Ghazal Zandieh, Yash Singh, Thomas DeSilvio, and Brennan Flannery speak with Dr. Joseph Ippolito about how metabolic imaging is transforming cancer diagnosis and treatment through advanced PET and MRI techniques. Together they explore how personalized medicine and sex-specific metabolic differences are reshaping the way radiologists understand and treat glioblastoma. Radiology: Imaging Cancer Journal

In this episode, we begin with a brief introduction of our podcasters, Tom DeSilvio, Brennan Flannery, Yash Singh, and Ghazal Zandieh, before welcoming Dr. Gary Luker, Editor‑in‑Chief of the RSNA journal, Radiology: Imaging Cancer. Our goal is to showcase and better introduce the journal while highlighting the future of individualized cancer imaging. Dr. Luker joins us to discuss how advanced imaging, artificial intelligence, and translational research are transforming personalized cancer care. Radiology: Imaging Cancer Journal

Dr. Brandon K.K. Fields speaks with Dr. Jennifer Holter-Chakrabarty about her groundbreaking research on fluorine-18 fluorothymidine (FLT) PET in the imaging of gastrointestinal graft-versus-host disease (GVHD) after allogeneic stem cell transplantation. Together, they explore a potential future role for FLT-PET in detection of early and/or subclinical GVHD, which may serve to guide future treatment strategies for transplant patients in years to come. 18F-FLT PET and Blood-based Biomarkers for IdentifyingGastrointestinal Graft versus Host Disease after Allogeneic CellTransplantation. Holter-Chakrabarty and McNally et al. Radiology: Imaging Cancer 2025; 7(1):e240096.

Dr. Lauren Burkard-Mandel discusses the importance of breast cancer screening at age 40 with guest Dr. Debra Monticciolo. They explore the 2023 U.S. Preventive Services Task Force's draft statement advocating for the initiation of biennial mammograms at age 40, down from the previous age of 50. Tune in for an insightful discussion that could impact women's health decisions for years to come! Articles discussed: https://doi.org/10.1093/jbi/wbad103 https://doi.org/10.1002/cncr.33846